Stock Markets Analysis & Opinion

Shipping name FedEx Corporation (NYSE:FDX) is up 1.6% at $180.91 in afternoon trading, despite earlier receiving a pre-earnings price-target cut to $230 from $235 at Raymond James. The company's...

Tuesday, March 19, 2019The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported a loss of 14 cents per share in the fourth quarter of 2018, wider than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss...

Have you noticed the absolute carnage taking place in the U.S. shale oil stocks? It seems as if Wall Street and investors are finally starting to grow weary of an industry that hasn’t made money...

S&P 500 (SPY)Stocks finished the day higher with the S&P 500 climbing by nearly 40 basis point to 2,833. At this point, there is very standing in the way between the S&P 500 and its...

One of my favorite analytical techniques for generating insights on global markets is studying market breadth, and those who know me know I like to take a bit of an alternative angle, and today's...

Daily Markets Broadcast March 19, 2019Wall Street continues its rally Wall Street indices extended last week’s gains into Monday, fueled by positive news on trade talks in the agricultural...

Another day of small gains yesterday, kept the rally moving for another day. The Russell 2000 probably got the most out of yesterday as the index closed at its 20-day MA.It is now in a position to...

On Mar 18, Canadian cannabis grower Tilray Inc. (NASDAQ:TLRY) reported fourth quarter and 2018 earnings after market close. Revenues of $15.5 million in the quarter boosted full-year sales to $43.1...

For Immediate ReleaseChicago, IL – March 19, 2019 – Zacks Equity Research Hilton Worldwide Holdings Inc. (NYSE:HLT) as the Bull of the Day, Toll Brothers, Inc. (NYSE:TOL) as the Bear...

Don’t look now, but 2019 may be shaping up to continue an Initial Public Offering (IPO) market that had been dormant just a few short years ago. This year may have gotten off to a slower start...

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced that it has initiated dosing in a phase II study to evaluate its investigational pipeline candidate, AR-1105, for treating patients with macular...

Synopsys, Inc. (NASDAQ:SNPS) recently introduced its updated version of IC Validator — IC Validator NXT — to meet the physical verification engineers’ advanced and important...

For Immediate ReleaseChicago, IL – March 19, 2019 - Stocks in this week’s article are Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) , Ligand Pharmaceuticals Inc. (NASDAQ:LGND) , Key...